20
Glaxosmithkline Research & Development Limited Greenford Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Zidovudine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-321 - Rev 00
This Chemical Type CEP, issued on March 06, 2008, remains in force until August 01, 2014, ensuring its reliability within the pharmaceutical industry.
Substance Number 1059 associated with this CEP further emphasizes